Cutaneous fibrosis induced by docetaxel
β
Mark G. Cleveland; B. S. Ajaikumar; Rohini Reganti
π
Article
π
2000
π
John Wiley and Sons
π
English
β 381 KB
## Background: Docetaxel is a taxoid antineoplastic agent approved for use in the treatment of metastatic breast carcinoma. the current study reports an unusual case of generalized cutaneous fibrosis in a 39-year-old white female after treatment with 18 cycles of docetaxel for metastatic breast car